{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "THE deciphering of the human genome, announced last week by rival public and private teams, promises to change the practice of medicine in profound ways in the decades to come. But for investors, whose focus may be a bit more short term, surprisingly little changed last week. Investing in medicine, whether the stocks of pharmaceutical giants or smaller biotechnology concerns, has always been about identifying those groups most likely to turn scientific discoveries into safe, effective drugs, and to manufacture and market them efficiently. One can also invest in tools companies -- the providers of chemical reagents, laboratory equipment and, increasingly, data, that are used to discover and develop new drugs, although these products usually offer lower margins.", "headline": {"main": "Investing; The Gene Angle on Medical Shares"}, "abstract": "Mapping of human genome is not likely to be of much immediate consequence for investors in medical sector, though breakthrough will ultimately have impact in many areas, particularly pharmaceutical industry; key will be to identify companies with management that has vision to apply the new science successfully; drawing, graphs (M)", "print_page": "8", "word_count": 851, "_id": "4fd208758eb7c8105d773120", "snippet": "THE deciphering of the human genome, announced last week by rival public and private teams, promises to change the practice of medicine in profound ways in the decades to come. But for investors, whose focus may be a bit more short term, surprisingly...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/07/02/business/investing-the-gene-angle-on-medical-shares.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "HUMAN GENOME PROJECT"}, {"name": "organizations", "value": "CELERA GENOMICS GROUP"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By LAWRENCE M. FISHER"}, "document_type": "article", "pub_date": "2000-07-02T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine Desk", "lead_paragraph": "I am sound asleep. The phone rings. I fumble for the receiver in the dark. James is calling collect. ''I'm at 125th Street and need a token,'' he says. I strain my neck to see my bedside clock and flop back on my pillow, groaning.", "headline": {"main": "The Vanity of Volunteerism"}, "abstract": "Sara Mosle article on serving as unofficial mentor to families of four of her former students in New York public school; focuses on experiences she has had with the children and why volunteerism does not work; photos (M)", "print_page": "22", "word_count": 8213, "_id": "4fd1fa558eb7c8105d757bd4", "snippet": "I am sound asleep. The phone rings. I fumble for the receiver in the dark. James is calling collect.    ''I'm at 125th Street and need a token,'' he says.     I strain my neck to see my bedside clock and flop back on my pillow, groaning.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/07/02/magazine/the-vanity-of-volunteerism.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK CITY"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "VOLUNTEERS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sara", "lastname": "Mosle"}], "original": "By Sara Mosle"}, "document_type": "article", "pub_date": "2000-07-02T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Attacking the pharmaceutical industry for engaging in ''corporate chutzpah'' and for ''gouging the consumer unfairly,'' Vice President Al Gore said today that he would take on the drug manufacturers next week at campaign stops in battleground states from California to Pennsylvania. In an interview on the veranda of his home here, Mr. Gore cast himself as a longtime critic of what he said were the industry's excessive prices and profits.", "headline": {"main": "Gore Tries Pitching Himself As Drug Industry Opponent", "kicker": "THE 2000 CAMPAIGN: THE PRESCRIPTION DRUG ISSUE"}, "abstract": "Vice Pres Al Gore, attacking pharmaceutical industry for engaging in 'corporate chutzpah' and for 'gouging the consumer unfairly,' says that he will take on drug manufacturers next week at campaign stops in battleground states from California to Pennsylvania, int; casts himself as longtime critic of what he contends are industry's excessive prices and profits (M)/", "print_page": "1", "word_count": 1305, "_id": "4fd225248eb7c8105d7abecc", "snippet": "Attacking the pharmaceutical industry for engaging in ''corporate chutzpah'' and for ''gouging the consumer unfairly,'' Vice President Al Gore said today that he would take on the drug manufacturers next week at campaign stops in battleground states...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/07/01/us/2000-campaign-prescription-drug-issue-gore-tries-pitching-himself-drug-industry.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GORE, AL"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2000"}], "byline": {"person": [{"firstname": "Sheryl", "middlename": "Gay", "lastname": "STOLBERG", "rank": 1, "role": "reported", "organization": ""}], "original": "By SHERYL GAY STOLBERG"}, "document_type": "article", "pub_date": "2000-07-01T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 3, "offset": 0, "time": 67}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}